UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 177 filers reported holding UNIQURE NV in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $106,000 | -48.8% | 5,668 | +23.4% | 0.02% | -54.0% |
| Q2 2020 | $207,000 | -5.0% | 4,594 | 0.0% | 0.05% | -32.4% |
| Q1 2020 | $218,000 | -33.7% | 4,594 | 0.0% | 0.07% | +2.8% |
| Q4 2019 | $329,000 | -8.4% | 4,594 | 0.0% | 0.07% | -6.5% |
| Q2 2019 | $359,000 | +31.0% | 4,594 | 0.0% | 0.08% | +28.3% |
| Q1 2019 | $274,000 | +35.6% | 4,594 | -17.2% | 0.06% | +30.4% |
| Q3 2018 | $202,000 | -3.3% | 5,549 | +0.2% | 0.05% | -23.3% |
| Q2 2018 | $209,000 | – | 5,538 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |